PDB Short entry for 2C1E
HEADER    HYDROLASE/HYDROLASE INHIBITOR           14-SEP-05   2C1E              
TITLE     CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL   
TITLE    2 ACCEPTOR INHIBITORS.                                                 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: CASPASE-3 SUBUNIT P17;                                     
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: ALPHA SUBUNIT, RESIDUES 29-175;                            
COMPND   5 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-
COMPND   6 32, SREBP CLEAVAGE ACTIVITY 1, SCA-1;                                
COMPND   7 EC: 3.4.22.-;                                                        
COMPND   8 ENGINEERED: YES;                                                     
COMPND   9 MOL_ID: 2;                                                           
COMPND  10 MOLECULE: CASPASE-3 SUBUNIT P12;                                     
COMPND  11 CHAIN: B;                                                            
COMPND  12 FRAGMENT: BETA SUBUNIT, RESIDUES 176-277;                            
COMPND  13 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-
COMPND  14 32, SREBP CLEAVAGE ACTIVITY 1, SCA-1;                                
COMPND  15 ENGINEERED: YES;                                                     
COMPND  16 MOL_ID: 3;                                                           
COMPND  17 MOLECULE: AZA-PEPTIDE INHIBITOR (5S, 8R, 11S)-8-(2-CARBOXYETHYL)-5-  
COMPND  18 (CARBOXYMETHYL)-14-(4-ETHOXY-4-OXOBUTANOYL)-11-(1-METHYLETHYL)-3,6,9,
COMPND  19 12-TETRAOXO-1-PHENYL-2-OXA-4,7,10,13,14-PENTAAZAHEXADECAN -16-OIC    
COMPND  20 ACID;                                                                
COMPND  21 CHAIN: C;                                                            
COMPND  22 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 469008;                                     
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);                                 
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_VECTOR: PET11D;                                    
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  12 ORGANISM_COMMON: HUMAN;                                              
SOURCE  13 ORGANISM_TAXID: 9606;                                                
SOURCE  14 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE  15 EXPRESSION_SYSTEM_TAXID: 469008;                                     
SOURCE  16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);                                 
SOURCE  17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  18 EXPRESSION_SYSTEM_VECTOR: PET11D;                                    
SOURCE  19 MOL_ID: 3;                                                           
SOURCE  20 SYNTHETIC: YES;                                                      
SOURCE  21 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;                            
SOURCE  22 ORGANISM_TAXID: 32630                                                
KEYWDS    APOPTOSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, CYSTEINE-PROTEASE,  
KEYWDS   2 THIOL PROTEASE, ZYMOGEN, CPP32, YAMA, AZA-PEPTIDE, MICHAEL ACCEPTOR, 
KEYWDS   3 AZA-ASP, CLAN CD                                                     
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    M.G.GRUTTER                                                           
REVDAT   7   15-NOV-23 2C1E    1       LINK   ATOM                              
REVDAT   6   28-JUN-17 2C1E    1       REMARK                                   
REVDAT   5   11-JAN-17 2C1E    1       SOURCE REMARK                            
REVDAT   4   20-JUL-11 2C1E    1       COMPND SOURCE KEYWDS REVDAT              
REVDAT   4 2                   1       REMARK                                   
REVDAT   3   13-JUL-11 2C1E    1       VERSN                                    
REVDAT   2   24-FEB-09 2C1E    1       VERSN                                    
REVDAT   1   20-SEP-06 2C1E    0                                                
JRNL        AUTH   O.D.EKICI,Z.Z.LI,A.J.CAMPBELL,K.E.JAMES,J.L.ASGIAN,          
JRNL        AUTH 2 J.MIKOLAJCZYK,G.S.SALVESEN,R.GANESAN,S.JELAKOVIC,            
JRNL        AUTH 3 M.G.GRUTTER,J.C.POWERS                                       
JRNL        TITL   DESIGN, SYNTHESIS, AND EVALUATION OF AZA-PEPTIDE MICHAEL     
JRNL        TITL 2 ACCEPTORS AS SELECTIVE AND POTENT INHIBITORS OF CASPASES-2,  
JRNL        TITL 3 -3, -6, -7, -8, -9, AND - 10.                                
JRNL        REF    J.MED.CHEM.                   V.  49  5728 2006              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   16970398                                                     
JRNL        DOI    10.1021/JM0601405                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.77 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.1                                              
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-              
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,              
REMARK   3               : READ,RICE,SIMONSON,WARREN                            
REMARK   3                                                                      
REMARK   3  REFINEMENT TARGET : NULL                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 19.65                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 1797719.970                    
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 96.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 25781                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.163                           
REMARK   3   FREE R VALUE                     : 0.188                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 9.900                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 2541                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.004                           
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 6                            
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.76                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.87                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 89.10                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 3558                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2170                       
REMARK   3   BIN FREE R VALUE                    : 0.2460                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 10.20                        
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 405                          
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.012                        
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2045                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 414                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 12.70                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 15.60                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.01000                                              
REMARK   3    B22 (A**2) : 0.55000                                              
REMARK   3    B33 (A**2) : -1.56000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.15                            
REMARK   3   ESD FROM SIGMAA              (A) : 0.10                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.18                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.11                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.005                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.300                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 23.10                           
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.640                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED                                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.030 ; 1.500                
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 1.510 ; 2.000                
REMARK   3   SIDE-CHAIN BOND              (A**2) : 2.070 ; 2.000                
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 2.970 ; 2.500                
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED : FLAT MODEL                                           
REMARK   3   KSOL        : 0.34                                                 
REMARK   3   BSOL        : 67.35                                                
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM                              
REMARK   3  PARAMETER FILE  2  : WATER.PARAM                                    
REMARK   3  PARAMETER FILE  3  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP                                    
REMARK   3  TOPOLOGY FILE  2   : NULL                                           
REMARK   3  TOPOLOGY FILE  3   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2C1E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-SEP-05.                  
REMARK 100 THE DEPOSITION ID IS D_1290025549.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 04-JAN-05                          
REMARK 200  TEMPERATURE           (KELVIN) : 100.0                              
REMARK 200  PH                             : 4.75                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : ENRAF-NONIUS FR591                 
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : MOSFLM                             
REMARK 200  DATA SCALING SOFTWARE          : SCALA                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 25781                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.760                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 20.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.3                               
REMARK 200  DATA REDUNDANCY                : 4.300                              
REMARK 200  R MERGE                    (I) : 0.05000                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 19.1000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.86                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 87.8                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.00                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.21000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 6.600                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS            
REMARK 200 SOFTWARE USED: NULL                                                  
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 36.72                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, 100 MM SODIUM CITRATE PH 4.75   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,-Y,Z                                                 
REMARK 290       3555   -X,Y,-Z                                                 
REMARK 290       4555   X,-Y,-Z                                                 
REMARK 290       5555   X+1/2,Y+1/2,Z+1/2                                       
REMARK 290       6555   -X+1/2,-Y+1/2,Z+1/2                                     
REMARK 290       7555   -X+1/2,Y+1/2,-Z+1/2                                     
REMARK 290       8555   X+1/2,-Y+1/2,-Z+1/2                                     
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000       33.40000            
REMARK 290   SMTRY2   5  0.000000  1.000000  0.000000       41.91000            
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000       48.18000            
REMARK 290   SMTRY1   6 -1.000000  0.000000  0.000000       33.40000            
REMARK 290   SMTRY2   6  0.000000 -1.000000  0.000000       41.91000            
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       48.18000            
REMARK 290   SMTRY1   7 -1.000000  0.000000  0.000000       33.40000            
REMARK 290   SMTRY2   7  0.000000  1.000000  0.000000       41.91000            
REMARK 290   SMTRY3   7  0.000000  0.000000 -1.000000       48.18000            
REMARK 290   SMTRY1   8  1.000000  0.000000  0.000000       33.40000            
REMARK 290   SMTRY2   8  0.000000 -1.000000  0.000000       41.91000            
REMARK 290   SMTRY3   8  0.000000  0.000000 -1.000000       48.18000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC                  
REMARK 350 SOFTWARE USED: PQS                                                   
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C                               
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -1.000000  0.000000  0.000000       66.80000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000       96.36000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 THE INITIAL LIGAND USED IN THE EXPERIMENT WAS TRANS CBZ-DEVAD-CH=CH  
REMARK 400 -CO2ET, INDICATED AS 18H IN THE PRIMARY PUBLICATION. UPON REACTION,  
REMARK 400 THE DOUBLE BOND OPENED UP AND FORMED A COVALENT BOND BETWEEN ATOM    
REMARK 400 C11 OF RESIDUE AA1 5 OF CHAIN C AND ATOM SG OF CYS 163 OF CHAIN A.   
REMARK 400 ACTIVATE CASCADE OF CASPASES AND RESPONSIBLE FOR APOPTOSIS           
REMARK 400 EXECUTION.                                                           
REMARK 400                                                                      
REMARK 400 THE (5S,8R,11S)-8-(2-CARBOXYETHYL)-5-(CARBOXYMETHYL)-14-(4-ETHOXY-4- 
REMARK 400 OXOBUTANOYL)-11-(1-METHYLETHYL)-3,6,9,12-TETRAOXO-1-PHENYL-2-OXA-4,  
REMARK 400 7,10,13,14-PENTAAZAHEXADECAN-16-OIC ACID IS PEPTIDE-LIKE, A MEMBER   
REMARK 400 OF INHIBITOR CLASS.                                                  
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: (5S,8R,11S)-8-(2-CARBOXYETHYL)-5-(CARBOXYMETHYL)-14-(4-      
REMARK 400         ETHOXY-4-OXOBUTANOYL)-11-(1-METHYLETHYL)-3,6,9,12-TETRAOXO-  
REMARK 400         1-PHENYL-2-OXA-4,7,10,13,14-PENTAAZAHEXADECAN-16-OIC ACID    
REMARK 400   CHAIN: C                                                           
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: NULL                                                  
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     ASP A 175    CA   C    O    CB   CG   OD1  OD2                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ARG A  64       77.80   -105.09                                   
REMARK 500    SER A 120     -175.40   -174.23                                   
REMARK 500    LYS B 229      -32.43   -137.11                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A2046        DISTANCE =  6.15 ANGSTROMS                       
REMARK 525    HOH A2064        DISTANCE =  5.88 ANGSTROMS                       
REMARK 525    HOH A2069        DISTANCE =  5.87 ANGSTROMS                       
REMARK 525    HOH A2093        DISTANCE =  6.07 ANGSTROMS                       
REMARK 525    HOH B2002        DISTANCE =  5.84 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF AZA-PEPTIDE            
REMARK 800  INHIBITOR (5S,8R,11S)-8-(2-CARBOXYETHYL)-5-(CARBOXYMETHYL)-14-(4-   
REMARK 800  ETHOXY-4-OXOBUTANOYL)-11-(1-METHYLETHYL)-3,6,9,12-TETRAOXO-1-       
REMARK 800  PHENYL- 2-OXA-4,7,10,13,14-PENTAAZAHEXADECAN-16-OIC ACID            
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1CP3   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE    
REMARK 900 INHIBITOR ACE-DVAD- FMC                                              
REMARK 900 RELATED ID: 1GFW   RELATED DB: PDB                                   
REMARK 900 THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN ORCPP32)IN  
REMARK 900 COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR.                        
REMARK 900 RELATED ID: 1I3O   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP- BIR2 AND CASPASE 3         
REMARK 900 RELATED ID: 1NME   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE                         
REMARK 900 RELATED ID: 1NMQ   RELATED DB: PDB                                   
REMARK 900 EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS                  
REMARK 900 RELATED ID: 1NMS   RELATED DB: PDB                                   
REMARK 900 CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR                         
REMARK 900 RELATED ID: 1PAU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE    
REMARK 900 ALDEHYDE INHIBITOR AC -DEVD-CHO                                      
REMARK 900 RELATED ID: 1QX3   RELATED DB: PDB                                   
REMARK 900 CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OFUNLIGANDED HUMAN    
REMARK 900 CASPASE-3                                                            
REMARK 900 RELATED ID: 1RE1   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACIDALDEHYDE         
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 1RHJ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH APRYAZINONE      
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 1RHK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH A PHENYL-PROPYL- 
REMARK 900 KETONE INHIBITOR                                                     
REMARK 900 RELATED ID: 1RHM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH ANICOTINIC ACID  
REMARK 900 ALDEHYDE INHIBITOR                                                   
REMARK 900 RELATED ID: 1RHQ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH                  
REMARK 900 ABROMOMETHOXYPHENYL INHIBITOR                                        
REMARK 900 RELATED ID: 1RHR   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH ACINNAMIC ACID   
REMARK 900 METHYL ESTER INHIBITOR                                               
REMARK 900 RELATED ID: 1RHU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE -3 WITH A 5,6,           
REMARK 900 7TRICYCLIC PEPTIDOMIMETIC INHIBITOR                                  
REMARK 900 RELATED ID: 2C2K   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL  
REMARK 900 ACCEPTOR INHIBITORS.                                                 
REMARK 900 RELATED ID: 2C2M   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL  
REMARK 900 ACCEPTOR INHIBITORS.                                                 
REMARK 900 RELATED ID: 2C2O   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL  
REMARK 900 ACCEPTOR INHIBITORS.                                                 
REMARK 900 RELATED ID: 2CDR   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE  
REMARK 900 INHIBITORS.                                                          
REMARK 900 RELATED ID: 2CJX   RELATED DB: PDB                                   
REMARK 900 EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH         
REMARK 900 RESOLUTION X-RAY STRUCTURE ANALYSIS                                  
REMARK 900 RELATED ID: 2CJY   RELATED DB: PDB                                   
REMARK 900 EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH         
REMARK 900 RESOLUTION X-RAY STRUCTURE ANALYSIS                                  
REMARK 900 RELATED ID: 2CNK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE  
REMARK 900 INHIBITORS.                                                          
REMARK 900 RELATED ID: 2CNL   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE  
REMARK 900 INHIBITORS.                                                          
REMARK 900 RELATED ID: 2CNN   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE  
REMARK 900 INHIBITORS.                                                          
REMARK 900 RELATED ID: 2CNO   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE  
REMARK 900 INHIBITORS.                                                          
REMARK 900 RELATED ID: 2J30   RELATED DB: PDB                                   
REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND         
REMARK 900 ACTIVITY OF (PRO) CASPASE-3                                          
REMARK 900 RELATED ID: 2J31   RELATED DB: PDB                                   
REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND         
REMARK 900 ACTIVITY OF(PRO)CASPASE -3                                           
REMARK 900 RELATED ID: 2J32   RELATED DB: PDB                                   
REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND         
REMARK 900 ACTIVITY OF(PRO)CASPASE -3                                           
REMARK 900 RELATED ID: 2J33   RELATED DB: PDB                                   
REMARK 900 THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND         
REMARK 900 ACTIVITY OF (PRO) CASPASE-3                                          
DBREF  2C1E A   29   175  UNP    P42574   CASP3_HUMAN     29    175             
DBREF  2C1E B  175   175  PDB    2C1E     2C1E           175    175             
DBREF  2C1E B  176   277  UNP    P42574   CASP3_HUMAN    176    277             
DBREF  2C1E C    1     5  PDB    2C1E     2C1E             1      5             
SEQRES   1 A  147  SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR          
SEQRES   2 A  147  PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN          
SEQRES   3 A  147  PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR          
SEQRES   4 A  147  ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN          
SEQRES   5 A  147  LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG          
SEQRES   6 A  147  GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU          
SEQRES   7 A  147  ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU          
SEQRES   8 A  147  SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY          
SEQRES   9 A  147  PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY          
SEQRES  10 A  147  ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE          
SEQRES  11 A  147  ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY          
SEQRES  12 A  147  ILE GLU THR ASP                                              
SEQRES   1 B  103  ALA SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE          
SEQRES   2 B  103  PRO VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA          
SEQRES   3 B  103  PRO GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER          
SEQRES   4 B  103  TRP PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR          
SEQRES   5 B  103  ALA ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL          
SEQRES   6 B  103  ASN ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE          
SEQRES   7 B  103  ASP ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE          
SEQRES   8 B  103  VAL SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS              
SEQRES   1 C    5  PHQ ASP GLU VAL AA1                                          
HET    PHQ  C   1      10                                                       
HET    AA1  C   5      15                                                       
HETNAM     PHQ BENZYL CHLOROCARBONATE                                           
HETNAM     AA1 [1-(4-ETHOXY-4-OXOBUTANOYL)HYDRAZINO]ACETIC ACID                 
FORMUL   3  PHQ    C8 H7 CL O2                                                  
FORMUL   3  AA1    C8 H14 N2 O5                                                 
FORMUL   4  HOH   *414(H2 O)                                                    
HELIX    1   1 HIS A   56  GLY A   60  5                                   5    
HELIX    2   2 GLY A   66  ASN A   80  1                                  15    
HELIX    3   3 THR A   92  LYS A  105  1                                  14    
HELIX    4   4 LEU A  136  PHE A  142  1                                   7    
HELIX    5   5 CYS A  148  THR A  152  5                                   5    
HELIX    6   6 TRP B  214  ALA B  227  1                                  14    
HELIX    7   7 GLU B  231  PHE B  247  1                                  17    
HELIX    8   8 ASP B  253  HIS B  257  5                                   5    
SHEET    1  AA 6 GLU A  84  ASN A  89  0                                        
SHEET    2  AA 6 GLU A  43  ASN A  51  1  O  GLY A  45   N  GLU A  84           
SHEET    3  AA 6 ARG A 111  LEU A 119  1  N  SER A 112   O  GLU A  43           
SHEET    4  AA 6 LYS A 156  GLN A 161  1  O  LEU A 157   N  CYS A 116           
SHEET    5  AA 6 PHE B 193  TYR B 197  1  O  LEU B 194   N  PHE A 158           
SHEET    6  AA 6 CYS B 264  MET B 268 -1  O  CYS B 264   N  TYR B 197           
SHEET    1  AB 3 GLY A 122  GLU A 123  0                                        
SHEET    2  AB 3 ILE A 126  GLY A 129 -1  O  ILE A 126   N  GLU A 123           
SHEET    3  AB 3 GLY A 132  ASP A 135 -1  O  GLY A 132   N  GLY A 129           
SHEET    1  BA 2 ARG B 207  ASN B 208  0                                        
SHEET    2  BA 2 GLY B 212  SER B 213 -1  O  GLY B 212   N  ASN B 208           
LINK         SG  CYS A 163                 C11 AA1 C   5     1555   1555  1.86  
LINK         C1  PHQ C   1                 N   ASP C   2     1555   1555  1.33  
LINK         C   VAL C   4                 N   AA1 C   5     1555   1555  1.30  
SITE     1 AC1 27 MET A  61  SER A  63  ARG A  64  SER A  65                    
SITE     2 AC1 27 GLU A  84  SER A 120  HIS A 121  GLY A 122                    
SITE     3 AC1 27 GLN A 161  ALA A 162  CYS A 163  HOH A2070                    
SITE     4 AC1 27 ASP B 179  SER B 205  TRP B 206  ARG B 207                    
SITE     5 AC1 27 ASN B 208  SER B 209  SER B 249  PHE B 250                    
SITE     6 AC1 27 PHE B 252  HOH B2120  HOH C2267  HOH C2268                    
SITE     7 AC1 27 HOH C2269  HOH C2270  HOH C2271                               
CRYST1   66.800   83.820   96.360  90.00  90.00  90.00 I 2 2 2       8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.014970  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.011930  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.010378        0.00000